Vlachou, M. et al. 2023. Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis. Experimental Oncology. 43, 3 (May 2023), 252–256. DOI:https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16592.